Syntax Research, Inc.
- SEC CIK
- 0001999827
- Latest filing
- Jul 31, 2026
ELV holding history
Elevance Health, Inc. in every 13F filed by Syntax Research, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ELV overviewAll 13F holders of ELVFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q3 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −122−100.0% | Sold out | Holders |
| Q1 2026 | 122 | $35.7K | <0.1% | +1+0.8% | Added | Holders |
| Q4 2025 | 121 | $42.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 121 | $39.0K | <0.1% | −2,879−96.0% | Reduced | Holders |
| Q2 2025 | 3,000 | $1.17M | 0.8% | +3,000 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −37−100.0% | Sold out | Holders |
| Q3 2024 | 37 | $19.0K | <0.1% | +1+2.8% | Added | Holders |
| Q2 2024 | 36 | $19.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 36 | $18.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 36 | $17.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 36 | $15.7K | <0.1% | – | No prior filing | Holders |